ISS renews facility management contract with global pharmaceutical company

As part of the renewed contract, ISS will deliver integrated facility management services to offices, plasma donation centres, and manufacturing sites in various regions globally. In total, approximately 1000 ISS employees are expected to be servicing the pharmaceutical customer for the following five years.

The renewed contract has a slightly changed scope and annual revenue is above 1 pct. of Group revenue.

“I am very happy that we can continue our multi-year partnership on a global scale and keep supporting the important work that this company is doing in providing better health to the world,” said Andrew Price, Interim CEO of Global Key Accounts. “The contract is an acknowledgment of our many placemakers who have been delivering a dedicated service throughout the years.”

The scope of services in the renewed contract includes technical maintenance, facilities maintenance and repair, GMP cleaning and general cleaning, food and hospitality services, landscaping and security services as well as a broad variety of support services (mail, laundry, helpdesk, etc.). 

For media enquiries
Kenni Leth, Head of Global PR & Media Relations, +45 5171 4368

For investor enquiries
Jacob Johansen, Head of Group Investor Relations, +45 2169 3591
Louisa Grue Baruch, Senior Investor Relations Manager, +45 3817 6338